Bang Er Orthopedic

The group's business model centers on delivering comprehensive medical services for the diagnosis and treatment of a wide array of orthopedic conditions. Its areas of specialization include hand and foot surgery, traumatology, joint surgery, and spine surgery, complemented by rehabilitation medicine. For patients seeking alternatives to surgery, the company also provides non-invasive treatments for common ailments such as neck, shoulder, back, and leg pain. To support its clinical operations, the hospitals are outfitted with advanced medical technology, including 1.5T MRI scanners, 16-64 row spiral CTs, mobile C-arm surgical X-ray machines, and imported color ultrasound and discoscope equipment.

Financially, the company has demonstrated the ability to attract significant investment. In November 2023, Banger Orthopedic secured over CNY 800 million in a pre-IPO funding round. This Series D round was led by new investor Xiamen C&D Emerging Industry Equity Investment, with existing investors including Eight Roads Ventures, GP Capital, and Zhejiang United Investment Group also participating. The stated use for this capital infusion is to further the development of digital orthopedics within its specialty hospitals and to recruit additional talent in the orthopedic field.